231 related articles for article (PubMed ID: 12888625)
1. Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability.
Grover GJ; Mellström K; Ye L; Malm J; Li YL; Bladh LG; Sleph PG; Smith MA; George R; Vennström B; Mookhtiar K; Horvath R; Speelman J; Egan D; Baxter JD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):10067-72. PubMed ID: 12888625
[TBL] [Abstract][Full Text] [Related]
2. Development of the thyroid hormone receptor beta-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effects.
Grover GJ; Mellstrom K; Malm J
Cardiovasc Drug Rev; 2005; 23(2):133-48. PubMed ID: 16007230
[TBL] [Abstract][Full Text] [Related]
3. Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine.
Grover GJ; Egan DM; Sleph PG; Beehler BC; Chiellini G; Nguyen NH; Baxter JD; Scanlan TS
Endocrinology; 2004 Apr; 145(4):1656-61. PubMed ID: 14701670
[TBL] [Abstract][Full Text] [Related]
4. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential for thyroid hormone receptor-beta selective agonists for treating obesity, hyperlipidemia and diabetes.
Grover GJ; Mellström K; Malm J
Curr Vasc Pharmacol; 2007 Apr; 5(2):141-54. PubMed ID: 17430219
[TBL] [Abstract][Full Text] [Related]
6. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.
Bryzgalova G; Effendic S; Khan A; Rehnmark S; Barbounis P; Boulet J; Dong G; Singh R; Shapses S; Malm J; Webb P; Baxter JD; Grover GJ
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):262-7. PubMed ID: 18621127
[TBL] [Abstract][Full Text] [Related]
7. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.
Johansson L; Rudling M; Scanlan TS; Lundåsen T; Webb P; Baxter J; Angelin B; Parini P
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10297-302. PubMed ID: 16006512
[TBL] [Abstract][Full Text] [Related]
8. Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice.
Gullberg H; Rudling M; Saltó C; Forrest D; Angelin B; Vennström B
Mol Endocrinol; 2002 Aug; 16(8):1767-77. PubMed ID: 12145333
[TBL] [Abstract][Full Text] [Related]
9. Spared bone mass in rats treated with thyroid hormone receptor TR beta-selective compound GC-1.
Freitas FR; Moriscot AS; Jorgetti V; Soares AG; Passarelli M; Scanlan TS; Brent GA; Bianco AC; Gouveia CH
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1135-41. PubMed ID: 12965872
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice.
Weiss RE; Murata Y; Cua K; Hayashi Y; Seo H; Refetoff S
Endocrinology; 1998 Dec; 139(12):4945-52. PubMed ID: 9832432
[TBL] [Abstract][Full Text] [Related]
11. Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist.
Cable EE; Finn PD; Stebbins JW; Hou J; Ito BR; van Poelje PD; Linemeyer DL; Erion MD
Hepatology; 2009 Feb; 49(2):407-17. PubMed ID: 19072834
[TBL] [Abstract][Full Text] [Related]
12. [Thyroid hormone analogs: an important biological supply and new therapeutic possibilities].
Josseaume C; Lorcy Y
Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S33-6. PubMed ID: 18954857
[TBL] [Abstract][Full Text] [Related]
13. Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141.
Garg N; Li YL; Garcia Collazo AM; Litten C; Ryono DE; Zhang M; Caringal Y; Brigance RP; Meng W; Washburn WN; Agback P; Mellström K; Rehnmark S; Rahimi-Ghadim M; Norin T; Grynfarb M; Sandberg J; Grover G; Malm J
Bioorg Med Chem Lett; 2007 Aug; 17(15):4131-4. PubMed ID: 17543524
[TBL] [Abstract][Full Text] [Related]
14. The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity.
Trost SU; Swanson E; Gloss B; Wang-Iverson DB; Zhang H; Volodarsky T; Grover GJ; Baxter JD; Chiellini G; Scanlan TS; Dillmann WH
Endocrinology; 2000 Sep; 141(9):3057-64. PubMed ID: 10965874
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model.
Hashimoto K; Cohen RN; Yamada M; Markan KR; Monden T; Satoh T; Mori M; Wondisford FE
J Biol Chem; 2006 Jan; 281(1):295-302. PubMed ID: 16260782
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight.
Baxter JD; Webb P; Grover G; Scanlan TS
Trends Endocrinol Metab; 2004; 15(4):154-7. PubMed ID: 15109613
[TBL] [Abstract][Full Text] [Related]
17. A mouse model of resistance to thyroid hormone produced by somatic gene transfer of a mutant thyroid hormone receptor.
Hayashi Y; Mangoura D; Refetoff S
Mol Endocrinol; 1996 Jan; 10(1):100-6. PubMed ID: 8838149
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol.
Gullberg H; Rudling M; Forrest D; Angelin B; Vennström B
Mol Endocrinol; 2000 Nov; 14(11):1739-49. PubMed ID: 11075809
[TBL] [Abstract][Full Text] [Related]
19. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.
Takeda T; Suzuki S; Liu RT; DeGroot LJ
J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251
[TBL] [Abstract][Full Text] [Related]
20. Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-beta null mice abolishes the regulation of thyrotropin by thyroid hormone.
Abel ED; Moura EG; Ahima RS; Campos-Barros A; Pazos-Moura CC; Boers ME; Kaulbach HC; Forrest D; Wondisford FE
Mol Endocrinol; 2003 Sep; 17(9):1767-76. PubMed ID: 12819298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
